PanCD44 Immunohistochemical Evaluation in Prostatectomies from Patients with Adenocarcinoma

Introduction. CD44 has been proposed as a prognostic marker and a stem cell marker but studies in patients with prostate cancer have yielded inconsistent results. Patients and Methods. Patients submitted to radical prostatectomy between 2008 and 2013 at a university hospital were followed with biann...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	BioMed research international 2018-01, Vol.2018 (2018), p.1-7
Hauptverfasser:	da Cunha, Maria do Perpétuo Socorro Saldanha, Jamacaru, Francisco Vagnaldo Fechine, Cerqueira, João Batista Gadelha de, Santos, Adriele Machado dos, Hirth, Carlos Gustavo, Dornelas, Conceição Aparecida
Format:	Artikel
Sprache:	eng
Schlagworte:	Adenocarcinoma Adenocarcinoma - metabolism Adenocarcinoma - pathology Cancer Cancer patients Cancer surgery CD44 antigen Cell cycle Cell growth Cloning Correlation analysis Epithelium Humans Hyaluronan Receptors - metabolism Immunohistochemistry Immunohistochemistry - methods Inflammation Kinases Male Medical prognosis Metastasis Myc protein Neoplasm Grading - methods Neoplasm Recurrence, Local - metabolism Neoplasm Recurrence, Local - pathology Neoplastic Stem Cells - metabolism Neoplastic Stem Cells - pathology Oncology, Experimental Paraffin Pathology Patients Prognosis Prostate - metabolism Prostate - pathology Prostate cancer Prostate-Specific Antigen - metabolism Prostatectomy Prostatectomy - methods Prostatic Neoplasms - metabolism Prostatic Neoplasms - pathology Proteins Signal transduction Statistical analysis Stem cells Surgery Tissues Urological surgery Urology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!